Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Strojil

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|April 12, 2007
Early diagnosis of DIC development into the overt phaseJan Urge, Jan Strojil
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|March 22, 2017
A patient called Medical ResearchTomas Furst, Jan Strojil
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|April 8, 2006
Pharmacotherapeutical approaches to decreasing hematocrit and increasing claudication distance in diabetic patients with peripheral vascular diseaseJán Urge, Jan Strojil, Petr Utíkal
Personalized Medicine|May 18, 2018
A road toward better education in personalized medicine at universities and beyondMarie Karlikova, Jiri Polivka, Jan Strojil, et al.
Pharmacoepidemiology and Drug Safety|May 10, 2005
Utilization of fluoroquinolones and Escherichia coli resistance in urinary tract infection: inpatients and outpatientsKarel Urbánek, Milan Kolár, Jan Strojil, et al.
International Journal of Antimicrobial Agents|February 13, 2017
Is continuous infusion of imipenem always the best choice?Hana Suchánková, Michal Lipš, Karel Urbánek, et al.
International Journal of Antimicrobial Agents|September 14, 2014
Pharmacokinetics of imipenem in critically ill patients during empirical treatment of nosocomial pneumonia: a comparison of 0.5-h and 3-h infusionsMichal Lipš, Michal Siller, Jan Strojil, et al.
Biopharmaceutics & Drug Disposition|October 5, 2011
Fenofibrate-induced decrease of expression of CYP2C11 and CYP2C6 in ratRostislav Večeřa, Alice Zachařová, Jan Orolin, et al.
European Journal of Drug Metabolism and Pharmacokinetics|January 23, 2016
Effect of Lactobacillus casei on the Pharmacokinetics of Amiodarone in Male Wistar RatsZuzana Matuskova, Pavel Anzenbacher, Rostislav Vecera, et al.
Casopis Lekaru Ceskych|December 10, 2020
Exploratory drilling: how to set up, carry out, and evaluate a seroprevalence studyZuzana Krátká, Tomáš Fürst, Ondřej Vencálek, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|April 12, 2007
Early diagnosis of DIC development into the overt phaseJan Urge, Jan Strojil
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|March 22, 2017
A patient called Medical ResearchTomas Furst, Jan Strojil
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|April 8, 2006
Pharmacotherapeutical approaches to decreasing hematocrit and increasing claudication distance in diabetic patients with peripheral vascular diseaseJán Urge, Jan Strojil, Petr Utíkal
Personalized Medicine|May 18, 2018
A road toward better education in personalized medicine at universities and beyondMarie Karlikova, Jiri Polivka, Jan Strojil, et al.
Pharmacoepidemiology and Drug Safety|May 10, 2005
Utilization of fluoroquinolones and Escherichia coli resistance in urinary tract infection: inpatients and outpatientsKarel Urbánek, Milan Kolár, Jan Strojil, et al.
International Journal of Antimicrobial Agents|February 13, 2017
Is continuous infusion of imipenem always the best choice?Hana Suchánková, Michal Lipš, Karel Urbánek, et al.
International Journal of Antimicrobial Agents|September 14, 2014
Pharmacokinetics of imipenem in critically ill patients during empirical treatment of nosocomial pneumonia: a comparison of 0.5-h and 3-h infusionsMichal Lipš, Michal Siller, Jan Strojil, et al.
Biopharmaceutics & Drug Disposition|October 5, 2011
Fenofibrate-induced decrease of expression of CYP2C11 and CYP2C6 in ratRostislav Večeřa, Alice Zachařová, Jan Orolin, et al.
European Journal of Drug Metabolism and Pharmacokinetics|January 23, 2016
Effect of Lactobacillus casei on the Pharmacokinetics of Amiodarone in Male Wistar RatsZuzana Matuskova, Pavel Anzenbacher, Rostislav Vecera, et al.
Casopis Lekaru Ceskych|December 10, 2020
Exploratory drilling: how to set up, carry out, and evaluate a seroprevalence studyZuzana Krátká, Tomáš Fürst, Ondřej Vencálek, et al.
Pageof 2